GlassScriptPhysician profile
Ali Aminian
NPI 1710252184
$146,738.82
in general payments reported to CMS, 2019-2025
10 companies · $22K in 2025
The $22K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,067 · 2020: $5,700 · 2021: $262 · 2022: $20K · 2023: $39K · 2024: $57K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $110K · Travel and Lodging: $4,316 · Food and Beverage: $1,772 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $110,213.04 |
| Travel and Lodging | $4,315.88 |
| Food and Beverage | $1,771.97 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,425.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eli Lilly and Company | $100,957.23 | 2023-2025 | |
| Medical Device Business Services, INC. | $20,154.62 | 2022-2024 | Harmonic, Echelon Flex |
| Ethicon US, LLC | $8,418.51 | 2023-2024 | Echelon Flex, Harmonic, Echelon; Endopath |
| Covidien LP | $8,220.21 | 2019-2020 | |
| Medtronic, INC. | $8,196.15 | 2021-2025 | Signia, Avalus, Ligasure |
| Davol INC. | $546.72 | 2019 | |
| Boston Scientific Corporation | $115.72 | 2021 | |
| Intuitive Surgical, INC. | $69.15 | 2023 | Da Vinci Surgical System |
| Baxter Healthcare | $60.51 | 2023 | Tisseel |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Aminian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.